Lupin Limited
LUPIN
주식 순위
#2110
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
주가
$21.40
마지막 동기화: 2026-10-19
시가총액
$9.79B
변동 (1일)
-1.36%
변동 (1년)
-3.25%
국가
IN
거래 Lupin Limited (LUPIN)
카테고리
Healthcare
Lupin Limited (LUPIN)의 EPS
June 2026 기준 EPS TTM: $1.34
Lupin Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $1.34입니다. 2024년 말에는 회사의 EPS가 $0.50였으며, 이는 2023년의 EPS $0.12와 증가입니다.
Lupin Limited의 EPS 기록 (2004 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $1.34 | 58.99% |
| 2025 | $0.84 | 66.83% |
| 2024 | $0.50 | 338.14% |
| 2023 | $0.12 | -125.96% |
| 2022 | $-0.44 | -220.92% |
| 2021 | $0.37 | -413.07% |
| 2020 | $-0.12 | -171.84% |
| 2019 | $0.16 | 90.87% |
| 2018 | $0.09 | -90.23% |
| 2017 | $0.87 | 15.30% |
| 2016 | $0.76 | -11.63% |
| 2015 | $0.86 | -3.94% |
| 2014 | $0.89 | 65.13% |
| 2013 | $0.54 | 41.15% |
| 2012 | $0.38 | -11.79% |
| 2011 | $0.43 | 23.16% |
| 2010 | $0.35 | 47.14% |
| 2009 | $0.24 | -4.08% |
| 2008 | $0.25 | 43.29% |
| 2007 | $0.17 | 84.16% |
| 2006 | $0.09 | 84.60% |
| 2005 | $0.05 | 7.55% |
| 2004 | $0.05 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -58.35% |
IN
|
